Because of its very high bioavailability and its specific and direct action on protein synthesis, the investigators hypothesize that citrulline supplementation would be an innovative nutritional strategy to improve the peripheral muscle mass and strength in COPD patients with severe chronic respiratory failure. This supplementation would be more effective if the pathology is severe and the chronic systemic inflammation important. The benefits of this supplementation could help the most severe patients break out of the cycle of inactivity and thus optimize their quality of life. The main objective of this study is to evaluate the impact of 45-day nutritional supplementation with Citrulline (10 g / day) on the body composition (lean body mass) in malnourished COPD patients with severe chronic respiratory failure.
Denutrition in patients with COPD (Chronic Obstructive Pulmonary Disease) is characterized by muscle atrophy and loss of strength in the lower extremities. It worsens the symptomatology, exercise intolerance, impaired quality of life and prognosis of patients. Consequence of a protein deficiency associated with systemic inflammation, denutrition is becoming increasingly important in patients with chronic respiratory failure (CRF). L-citrulline is an amino acid having a direct action on muscle protein synthesis. The citrulline supplementation is an effective treatment to fight against muscle loss in aging subjects. Its impact on the functional and nutritional status of COPD patients has not been studied. Our main objective is to determine the impact of supplementation with Citrulline on mass and peripheral muscle strength in COPD with CRF. Our secondary objectives are to identify whether these benefits are dependent on the severity of the disease and if they are associated with increased physical activity, exercise tolerance and an improvement in symptoms and quality of life. This prospective, randomized, controlled, double-blind study will include 60 stable COPD patients (stage 3 and 4), with long-term oxygen therapy and / or non-invasive ventilation, BMI \<25 kg.m2 and suspicion of sarcopenia. For 45 days, patients will receive either citrulline (ProteoCIT®, 10mg) or placebo. The severity of COPD will be assessed by spirometry and blood gas data, the BODE index, exacerbations, comorbidities, nutritional status and systemic inflammation (CRPs, Fibrinogens). the investigators will evaluate before and after supplementation: body composition (DEXA), quadriceps strength and grip strength, walking speed, the exercise tolerance (6MWD), dyspnea (MMRC scales, BDI / TDI), quality of life (CAT and VSRQ questionnaires). Physical activity will be assessed by continuous actigraphy. This multicenter study will be conducted in 3 French hospitals: Grenoble, Nancy, Dijon.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
60
30 patients will be randomized into the group that will receive 10 mg of citrulline and 30 patients will be randomized into the placebo group for 45 days
30 patients will be randomized into the group that will receive 10 mg of citrulline and 30 patients will be randomized into the placebo group for 45 days
Hôpital François Mitterrand - CHU de Dijon
Dijon, France
Hôpitaux de Brabois - CHU de Nancy
Nancy, France
Impact of a 45-day nutritional supplementation with Citrulline (10 g / day) on body composition (lean body mass) of malnourished patients with COPD and severe chronic respiratory failure
Lean mass (kg.m-2) measured by DEXA
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on body composition
Regional variations of fat and bone mass measured by DEXA
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on muscular force
Grip force, Maximum strength of the quadriceps
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on tolerance to effort
3 min chair test
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on BODE stage
BODE score - The BODE score is composed of the following parameters: the body mass index, the post-bronchodilator FEV1 expressed as a percentage of the theoretical values (airflow obstruction), the dyspnoea score measured by the modified scale of the RCM ( Dyspnea) and the distance in meters traveled during a 6-minute walk test (Exercise).Each value of each parmeter corresponds to 1 point (from 0 to 4) and we add everything. The results are: score 0 to 2: mortality 15% at 4 years; and score 7 to 10: 80% mortality at 4 years
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
BMI
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on quality of life and dyspnea
Quality of life questionaries: COPD assessement Test (CAT): the participants answers differents questions that make it possible to measure the state of health of the patient.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on physical activity
Actigraphy
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on tolerance to effort
Pulmonary function test
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on tolerance to effort
Exacerbation number
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on tolerance to effort
Comorbidities
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on tolerance to effort
Blood gas results
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on quality of life and dyspnea
Quality of life questionaries: Visual Simplified respiratory questionary (VSRQ)
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on quality of life and dyspnea
Quality of life questionaries: Medical Research Council (mMRC)
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on quality of life and dyspnea
Quality of life questionaries: The baseline and Transition Dyspnea Indices (TDI/BDI scale)
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on quality of life and dyspnea
Quality of life questionaries: Disability Related to COPD tool (DIRECT) : a self-administered questionnaire designed to evaluate the impact of COPD on the patient's daily activities
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
MNA test : Mini Nutritional Assessment
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
a blood sample will be taken from the participants to measure the effects of citrulline on the inflammation and nutritional status of the patient. C reactive protein (CRPus), inflammation marker
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
Fibrinogen : inflammation marker that will be measured on a blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
Transthyretinemia biological parameter that will measure the nutritional status of the patient.will be mesasured on blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
Albuminemia : biological parameter that will measure the nutritional status of the patient.will be mesasured on blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
glycemia biological parameter that will measure the nutritional status of the patient.will be mesasured on blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
Insulinemia biological parameter that will measure the nutritional status of the patient. will be mesasured on blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
Acid-aminemia biological parameter that will measure the nutritional status of the patient. will be mesasured on blood sample.
Time frame: 45 days
Impact of a nutritional supplementation with Citrulline on inflammation and nutritional status
3 MethylHistine / urinary creatinine : this biological parameter will be measure on the urine: biological parameter measured on the urine. which will help to highlight the nutritional status of the patient.
Time frame: 45 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.